On Wednesday, Abbott Laboratories (NYSE: ABT) forecast 2025 profit that came in line with Wall Street estimates as it expects […]
Abbott Banks on Glucose Monitors, New Launches to Ride Out China, Currency Hit Read More »
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott (NYSE: ABT), Reckitt’s Mead
Abbott and Reckitt Face Trial Over Premature Baby Formula Amid Alarm From Doctors Read More »
Abbott Laboratories (NYSE: ABT) has launched its over-the-counter continuous glucose monitoring system in the U.S., the company said on Thursday,
Abbott (NYSE: ABT) Debuts OTC Glucose Monitoring System in the US, Rivals Dexcom Read More »
On Monday, Abbott Laboratories (NYSE: ABT) shares fell nearly 7% premarket, while British peer Reckitt Benckiser slumped 9% after the
Abbott (NYSE: ABT) Hit with $495 Million Penalty in Infant Formula Case, Stock Slides Read More »
Similac baby formula maker Abbott (NYSE: ABT) is expected to face a trial on Monday over claims that its formula
Abbott (NYSE: ABT) Faces Trial Over Claims of Infant Formula-Linked Disease Risks Read More »
Copyright © 2025 abbonews.com
